Research Paper Volume 16, Issue 1 pp 593—616
Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma
Figure 8. The risk score predicts sensitivity to immunotherapy and chemotherapy. (A) K-M survival analysis of the patients in the high and low risk subgroups according to the anti-PD-L1 cohort (IMvigor210 cohort). (B) The proportion of the immune response to anti-PD-L1 treatment in the high- and low-risk score subgroups. (C) Small molecule inhibitor screening based on the prediction model. (D) The IC50 values for anticancer drugs, chemotherapeutics, and targeted agents in the high- and low-risk subgroups.